News
By categorising obesity as a disease, public health systems and medical aid schemes around the world would be more likely to ...
In Part 1 of this Spotlight special briefing, we looked at some of the big picture dynamics of HIV in South Africa, and in ...
QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...
Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...
The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...
Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...
A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration (FDA) later this month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results